Structural formula: Sonidegib phosphate

ODOMZO 200 mg, hard capsule 30 capsules

Telegram WhatsApp

Link to share

Active ingredients: Sonidegib phosphate, Sonidegib

Commercialized according to BDPMDispensing in France: Prescription only

Hard capsule30 capsulesorale

No current ANSM shortage notice is included

Package details

Original BDPM fields are shown in French.

Official name: ODOMZO 200 mg, gélule
Pharmaceutical form: gélule
Route of administration: orale
Presentation description: plaquette(s) polychlortrifluoroéthylène PVC aluminium de 30 gélule(s)
Marketing authorisation holder: SUN PHARMACEUTICAL INDUSTRIES EUROPE (PAYS BAS)
Reimbursement according to BDPM: 100%
Approval for use in healthcare institutions: oui
Commercialization declaration date: 2 Mar 2018
Prescription and dispensing conditions: Prescription only
List I: prescription-only medicine
Requires special monitoring during treatment
Prescribed by a hospital doctor
Prescribed by specialists only
Original BDPM wording: liste I · médicament nécessitant une surveillance particulière pendant le traitement · pour les femmes susceptibles de procréer : surveillance particulière pendant le traitement · prescription hospitalière · prescription nécessitant préalablement le recueil de l’accord de soins du patient · prescription réservée aux médecins compétents en CANCEROLOGIE · prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE
Enhanced ANSM monitoring: No

BDPM identifiers

CIS65006905CIP73003072CIP133400930030721

Composition in BDPM

Composition in BDPM
Component	Amount per unit	Source type
SONIDÉGIBgélule	200 mg · une gélule	FT
PHOSPHATE DE SONIDÉGIBgélule	280,80 mg · une gélule	SA

Information is based on BDPM data and is for reference only. Consult a doctor before use.

Similar medicines

Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.

The current BDPM data does not list similar medicines for this product.